Innate Pharma SA (FRA:IDD)
€ 1.598 -0.02 (-1.24%) Market Cap: 130.33 Mil Enterprise Value: 74.03 Mil PE Ratio: 0 PB Ratio: 4.52 GF Score: 67/100

Q1 2021 Innate Pharma SA Earnings Call Transcript

May 11, 2021 / 01:00PM GMT
Release Date Price: €3.16 (-3.60%)
Operator

Good day, and thank you for standing by, and welcome to the Innate Pharma 2021 First Quarter Business Update Conference Call. (Operator Instructions) I must advise you that this call is being recorded today, Tuesday the 11th of May, 2021.

I would now like to hand the call over to your first speaker today, Dr. Mondher Mahjoubi. Please go ahead, sir.

Mondher Mahjoubi
Innate Pharma S.A. - Chairman of Executive Board & CEO

Thank you. Good morning, good afternoon, and welcome, everyone. This morning, Innate issued a press release providing a business update for the first quarter 2021. I look forward to explaining the progress made during the quarter, as well as addressing future goals and milestone. The press release and today's presentation are both available on the IR section of our website.

Please move to Slide #2. And before we start, I would like to remind you that we will make forward-looking statements regarding the financial outlook in addition to regulatory and product plan development. These statements are subject to risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot